SCHEMBL4744773

SCHEMBL4744773

NC(=O)N(c1ccc(O)c(O)c1)c1ccc(O)c(O)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.47
TDP1 Q9NUW8 5/20 0.47
HSD17B10 Q99714 4/20 0.47
POLB P06746 3/20 0.47
HPGD P15428 3/20 0.47
BLM P54132 3/20 0.47
HIF1A Q16665 3/20 0.47
RECQL P46063 3/20 0.47
RGS12 O14924 2/20 0.47
NFKB1 P19838 2/20 0.47
APEX1 P27695 2/20 0.47
GNAI1 P63096 2/20 0.47
MEN1 O00255 2/20 0.47
ALDH1A1 P00352 2/20 0.47
KMT2A Q03164 2/20 0.47
USP2 O75604 2/20 0.47
ALOX15 P16050 2/20 0.47
THRB P10828 1/20 0.47
PKM P14618 1/20 0.47
MAPK1 P28482 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9673110 0.81 KDM4E (0.46) KDM4ETDP1HSD17B10POLBHPGD
SCHEMBL6692569 0.76 KDM4E (0.42) KDM4ETDP1HSD17B10POLBHPGD
SCHEMBL11417635 0.75 ESR1 (0.43) KDM4EHSD17B10HPGDBLMHIF1A
SCHEMBL11804404 0.72 ALDH1A1 (0.52) KDM4ETDP1HSD17B10ALDH1A1KMT2A
SCHEMBL7983114 0.72 TSHR (0.42) HSD17B10APEX1MEN1ALDH1A1KMT2A
SCHEMBL3865856 0.72 IGF1R (0.45) KDM4ETDP1HSD17B10POLBHPGD
SCHEMBL9547587 0.71 ESR1 (0.49) KDM4ETDP1HSD17B10HPGDMEN1
SCHEMBL9674286 0.71 KDM4E (0.48) KDM4ETDP1HSD17B10POLBHPGD
SCHEMBL65464 0.70 ALDH1A1 (0.44) KDM4ETDP1HSD17B10POLBHIF1A
SCHEMBL11800568 0.70 KDM4E (0.52) KDM4ETDP1HSD17B10POLBHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008154083-A2 COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF SYNUCLEINOPATHIES PROTEO TECH INC. (US) 2008-12-18 WO claimed
EP-1751097-A1 SUBSTITUTED N-ARYL BENZAMIDES AND RELATED COMPOUNDS FOR TREATMENT OF AMYLOID DISEASES AND SYNUCLEINOPATHIES Proteotech, Inc. (US) 2007-02-14 EP claimed
WO-2005113489-A1 SUBSTITUTED N-ARYL BENZAMIDES AND RELATED COMPOUNDS FOR TREATMENT OF AMYLOID DISEASES AND SYNUCLEINOPATHIES PROTEOTECH, INC. (US) 2005-12-01 WO claimed
WO-2008154083-A2 COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF SYNUCLEINOPATHIES PROTEO TECH INC. (US) 2008-12-18 WO disclosed
WO-2008097692-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFLAMMATORY DISEASES PROTEOTECH INC. (US) 2008-08-14 WO disclosed
EP-1751097-A1 SUBSTITUTED N-ARYL BENZAMIDES AND RELATED COMPOUNDS FOR TREATMENT OF AMYLOID DISEASES AND SYNUCLEINOPATHIES Proteotech, Inc. (US) 2007-02-14 EP disclosed
WO-2005113489-A1 SUBSTITUTED N-ARYL BENZAMIDES AND RELATED COMPOUNDS FOR TREATMENT OF AMYLOID DISEASES AND SYNUCLEINOPATHIES PROTEOTECH, INC. (US) 2005-12-01 WO disclosed